It was an excellent appointment
Pharmacists may do this for people who cannot take the FDA-approved version of a drug
Products differ by cannabinoid content, dose, route, purity, and testing standards, so one paper cannot validate every product.What should patients ask their clinician?Patients should ask how the evidence relates to their own developmental and epileptic encephalopathies and complex treatment-resistant epilepsies, medication list, risks, goals, and monitoring plan.Are side effects still important if the findings are positive?Yes
GLP-1 therapies reduced inflammatory markers and protected kidney function in animals and humans, including in the FLOW trial
This differentiates it from earlier molecules (e.g., GHRP-6), which may exert broader endocrine effects